What is ALS? Experts explain symptoms to look out for ... - CBS News
WEBAug 9, 2023 · The news brought new attention to the disease and prompted questions about what the diagnosis means. ALS is a progressive neurodegenerative disease that affects nerve cells in the brain and...
Amyotrophic Lateral Sclerosis News -- ScienceDaily
WEB3 days ago · Latest research news on amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease, including experimental treatments.
FDA Approves First ALS Treatment Via Accelerated Approval
WEBApr 25, 2023 · Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease that affects nerve cells in the brain and spinal cord. Over the course of the disease, people lose the ability to move, to speak, and eventually, to breathe. On average, it takes about a year before a final ALS diagnosis is made.
New studies point the way to broadly effective treatments for ALS
WEBFeb 7, 2023 · Dec. 2, 2021 — The brain is indeed a target for treating ALS (amyotrophic lateral sclerosis), scientists have discovered. This flips a long-standing belief the disease starts in the spinal...
Discovery of hundreds of genes potentially associated with ALS …
WEBJan 18, 2022 · Stanford researchers identified a gene crucial to the formation of toxic proteins in amyotrophic lateral sclerosis and showed how it could inform potential therapies for the disease.
New therapeutic strategy to reduce neuronal death in amyotrophic ...
WEBNov 16, 2023 · Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease that affects neurons in the brain and spinal cord causing loss of muscle control. Scientists have now suggested a potential...
FDA approves controversial new drug designed to slow the ... - NBC News
WEBSep 30, 2022 · The Food and Drug Administration on Thursday approved a new drug to slow the progression of ALS, a fatal neurodegenerative disease for which there is no cure.
Epigenomic analysis sheds light on risk factors for ALS
WEBMay 2, 2024 · In a study of cells from nearly 400 amyotrophic lateral sclerosis (ALS) patients, MIT researchers identified genomic regions with chemical modifications linked to disease progression.
Researchers connect ALS hallmark to gene | News Center
WEBFeb 23, 2022 · Scientists who study amyotrophic lateral sclerosis know there are certain telltale features of the disease, and they occasionally find suspicious genes that seem to be connected to the development of ALS — but the two rarely align. Now, a study led by researchers at Stanford Medicine and the Mayo Clinic has confirmed a …
Mayo Clinic awarded federal grant to study experimental ALS drug
WEB3 days ago · Getty Images. JACKSONVILLE, Fla. — Mayo Clinic in Florida has received a grant from the National Institute of Neurological Disorders and Stroke (NIDS) to begin an innovative study that will provide hundreds of patients with amyotrophic lateral sclerosis (ALS) access to the experimental drug ibudilast over six …